Skip to main content
. 2013 Nov 26;28(12):1801–1806. doi: 10.3346/jkms.2013.28.12.1801

Table 2.

Results summary for samples tested for IFN-β antibodies: overall, 29.03% of serum samples were positive for BAbs, and 80.6% of BAbs-positive samples were NAbs-positive

graphic file with name jkms-28-1801-i002.jpg

IFN-β, interferon beta; N, the numbers of patients in each treatment group; BAbs, binding antibodies; NAbs, neutralizing antibodies.